HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G0S2 regulates innate immunity in Kawasaki disease via lncRNA HSD11B1-AS1.

AbstractBACKGROUND:
Kawasaki disease (KD) is a systemic vasculitis that is currently the most common cause of acquired heart disease in children. However, its etiology remains unknown. Long non-coding RNAs (lncRNAs) contribute to the pathophysiology of various diseases. Few studies have reported the role of lncRNAs in KD inflammation; thus, we investigated the role of lncRNA in KD inflammation.
METHODS:
A total of 50 patients with KD (median age, 19 months; 29 males and 21 females) were enrolled. We conducted cap analysis gene expression sequencing to determine differentially expressed genes in monocytes of the peripheral blood of the subjects.
RESULTS:
About 21 candidate lncRNA transcripts were identified. The analyses of transcriptome and gene ontology revealed that the immune system was involved in KD. Among these genes, G0/G1 switch gene 2 (G0S2) and its antisense lncRNA, HSD11B1-AS1, were upregulated during the acute phase of KD (P < 0.0001 and <0.0001, respectively). Moreover, G0S2 increased when lipopolysaccharides induced inflammation in THP-1 monocytes, and silencing of G0S2 suppressed the expression of HSD11B1-AS1 and tumor necrosis factor-α.
CONCLUSIONS:
This study uncovered the crucial role of lncRNAs in innate immunity in acute KD. LncRNA may be a novel target for the diagnosis of KD.
IMPACT:
This study revealed the whole aspect of the gene expression profile of monocytes of patients with Kawasaki disease (KD) using cap analysis gene expression sequencing and identified KD-specific molecules: G0/G1 switch gene 2 (G0S2) and long non-coding RNA (lncRNA) HSD11B1-AS1. We demonstrated that G0S2 and its antisense HSD11B1-AS1 were associated with inflammation of innate immunity in KD. lncRNA may be a novel key target for the diagnosis of patients with KD.
AuthorsMako Okabe, Shinya Takarada, Nariaki Miyao, Hideyuki Nakaoka, Keijiro Ibuki, Sayaka Ozawa, Kazuhiro Watanabe, Harue Tsuji, Ikuo Hashimoto, Kiyoshi Hatasaki, Shotaro Hayakawa, Yu Hamaguchi, Michiaki Hamada, Fukiko Ichida, Keiichi Hirono
JournalPediatric research (Pediatr Res) Vol. 92 Issue 2 Pg. 378-387 (08 2022) ISSN: 1530-0447 [Electronic] United States
PMID35292727 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Chemical References
  • Cell Cycle Proteins
  • G0S2 protein, human
  • RNA, Long Noncoding
  • Tumor Necrosis Factor-alpha
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
  • HSD11B1 protein, human
Topics
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
  • Cell Cycle Proteins
  • Child
  • Female
  • Humans
  • Immunity, Innate
  • Infant
  • Inflammation
  • Male
  • Mucocutaneous Lymph Node Syndrome (genetics)
  • RNA, Long Noncoding (genetics, metabolism)
  • Tumor Necrosis Factor-alpha

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: